|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7048 | (2006.01) |
| A61K 31/135 | (2006.01) | ||
| A61K 31/365 | (2006.01) | ||
| A61P 3/04 | (2006.01) |
| (11) | Number of the document | 2827874 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13710411.3 |
| Date of filing the European patent application | 2013-03-19 | |
| (97) | Date of publication of the European application | 2015-01-28 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/055671 |
| Date | 2013-03-19 |
| (87) | Number | WO 2013/139777 |
| Date | 2013-09-26 |
| (30) | Number | Date | Country code |
| 12160377 | 2012-03-20 | EP |
| (72) |
MAYOUX, Eric Williams , DE
GREMPLER, Rolf , DE
KLEIN, Thomas , DE
|
| (73) |
Boehringer Ingelheim International GmbH ,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (54) | PHARMACEUTICAL COMPOSITION COMPRISING EMPAGLIFLOZIN AND ANTIOBESITY DRUG |
| PHARMACEUTICAL COMPOSITION COMPRISING EMPAGLIFLOZIN AND ANTIOBESITY DRUG |